Previous Close | 5.89 |
Open | 5.97 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1300 |
Day's Range | 5.90 - 6.56 |
52 Week Range | 3.28 - 26.77 |
Volume | |
Avg. Volume | 1,431,983 |
Market Cap | 406.294M |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -11.69 |
Earnings Date | May 02, 2022 - May 06, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.85 |
ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will participate in a fireside chat at the upcoming H.C. Wainwright Global Investment Conference on Tuesday, May 24th, 2022. Event:H.C. Wainwright Global Investment ConferenceDate:Tuesday, May 24th, 2022Format:Presentation and 1:1 MeetingsTime:7:00 am Eastern Standard TimeWebcast:Link A live audio webcast can be accessed on the investor and media
Esperion Therapeutics, Inc. ( NASDAQ:ESPR ) is possibly approaching a major achievement in its business, so we would...
Esperion Therapeutics (ESPR) reports solid first-quarter results, beating estimates for earnings and sales. Cost-savings programs boost margins. Stock rallies.